The practical value of Blood Agar (Sheep Blood 7%) Culture Media is not the plate or broth alone; it is the reproducibility of the susceptibility endpoint produced from it. The discussion below connects its documented role with preparation variables, controls, interpretation, and the limits of inference. Catalogue 10142 is discussed as a laboratory measurement component; implementation should follow the laboratory SOP and validated reference method.

Analytical scope and method role

Blood Agar (Sheep Blood 7%) is a medium used for the cultivation of fastidious pathogenic organisms and detection of their haemolytic activity.This medium is recommended in ISO 7932 and ISO 11290-1 for confirmation of Bacillus cereus and Listeria monocytogenes, respectively.

Method principle

Proteose peptone and liver digest provide amino acid, carbon, nitrogen, vitamins and minerals for organisms growth. Yeast extract is a source of vitamins, particularly of B-group. Sodium chloride maintains the osmotic balance of the medium. Agar is the solidifying agent. Blood is included to provide additional growth factors for fastidious microorganisms and allows to demonstrate the haemolytic reactions.

Formula and functional interpretation

(g/l)Proteose Peptone15.0Liver Digest 2.5Yeast Extract 5.0Sodium Chloride 5.0Agar15.0Defibrinated Sheep Blood70.0 mlFinal pH 7.2 ± 0.2

Review the nutritive, selective, differential, buffering, reducing, and indicator components against the expected target and background flora. Preparation errors can change recovery, inhibition, colour development, or endpoint visibility even when incubation is correct.

Preparation and execution: controlled method points

Procedure: Inoculate the plates by the streak/spread method. Incubate under optimal conditions, usually 35 ± 2°C for 24-48 hours.To determine the haemolytic activity, after obtaining a pure culture, streak, stab or spot the selected colonies onto the medium in a manner which allows good

Translate the method into controlled worksheet fields: catalogue and lot, preparation mass or volume, water quality, pH where applicable, heating or sterilization, supplements, dispense volume, preparation date, expiry assignment, incubation atmosphere and temperature, reading window, equipment, and analyst. Record departures as deviations instead of silently normalizing them.

Quality control: what the control result protects

1.Control of general characteristics, label and print2.Sterility control7 days at 22 ± 2°C, in aerobiosis7 days at 35 ± 2°C, in aerobiosis3.Microbiological controlInoculum for productivity: 50-100 CFUIncubation Conditions: 18-24 hours at 35 ± 2°CMicroorganismGrowthHaemolysisStaphylococcus aureusATCC 25923Goodbeta-haemolysisStreptococcus pyogenes*ATCC 19615Goodbeta-haemolysisStreptococcus pneumoniae* ATCC 6303Goodα-haemolysisNeisseria meningitidis*ATCC 13090Goodγ-haemolysisListeria monocytogenes ATCC 19118Goodbeta-haemolysisBacillus cereusATCC 11778Goodbeta-haemolysisEscherichia coliATCC

Challenge both sides of performance. Include a target reaction demonstrating recovery and, when relevant, a non-target or alternate reaction challenging inhibition or differentiation. Record expected and observed responses, acceptance criteria, strain and passage, lot, incubation, and disposition. A failed control blocks result interpretation until the cause is resolved.

Interpretation and confirmation pathway

Examine the plates for growth and haemolytic reactions. Four types of haemolysis on blood agar media can be described:1.α-haemolysis is the reduction of hemoglobin to methemoglobin in the medium surrounding the colony, causing a greenish decolorization of the medium;2.beta-haemolysis is the lysis of red blood cells, producing a clear zone surrounding the colony;3.γ-haemolysis indicates no destruction of red blood cells and no change in the color of the medium;4.ά-haemolysis indicates a partial lysis.

Record the raw observation before the conclusion: morphology or colour, growth pattern, endpoint, reaction intensity, reading time, and control response. Presumptive reactions remain presumptive. Route atypical, weak, mixed, or delayed reactions through the confirmation step in the current method.

Storage, stability, and pre-use inspection

AND TRANSPORT CONDITIONS2-8°C away from light, until the expiry date on the label. However, our stability studies have shown that the transport at 18-25°C for 4 days, or at 35-39°C for 48 hours, does not alter in any way the

Receipt and storage records should reconstruct temperature exposure, lot rotation, expiry, container integrity, and time outside controlled storage. Inspect colour, clarity, fill volume, gel integrity, contamination, dehydration, and precipitate before use.

Limitations and boundaries of use

The product does not contain hazardous substances in concentrations exceeding the limits set by current legislation and therefore is notclassified as dangerous. It is nevertheless recommended to consult the safety data sheet for its correct use. The product is designed for In vitro diagnostic use and must be used only by properly trained operators.

Applicability depends on matrix, target organism, interfering flora, inoculum, validated method, and regulatory setting. Do not transfer conditions or acceptance criteria from a different matrix without verification.

Troubleshooting from evidence, not guesswork

  • Poor recovery: check preparation, pH, overheating, supplement addition, inoculum, atmosphere, storage, and control performance.
  • Loss of selectivity: review formulation, sterilization, expiry, inoculum burden, enrichment sequence, and incubation time.
  • Weak or atypical reaction: confirm reading time and atmosphere, compare controls, document mixed growth, and follow confirmation requirements.
  • Run-to-run drift: trend lot, analyst, equipment, water, preparation batch, controls, and environmental conditions.

External method context

The product should be understood as one measurement component in an antimicrobial susceptibility method. The analytical chain includes isolate purity, standardized inoculum, medium composition, antimicrobial concentration, incubation atmosphere and time, endpoint reading, and the interpretive table selected by the laboratory. A shift in any upstream variable can move an MIC or zone without a change in organism biology, which is why QC distributions and trend review are more informative than a single pass/fail control.

External laboratory-quality guidance also supports a lifecycle view: verify the method when introduced, bridge new lots against an accepted lot, trend control results, investigate nonconformities, and retain enough raw observations to reconstruct the decision. This is the practical difference between reproducing a preparation instruction and demonstrating that the resulting measurement is fit for its intended use.

FDA BAM Chapter 10: Detection of Listeria monocytogenes

FDA's Listeria method places selective enrichment and plating inside a staged detection workflow and requires confirmation of suspect isolates. The broader lesson is that injured or low-level cells, competing flora, and matrix carryover can affect apparent recovery; verification should therefore include stressed target cells, representative backgrounds, and a defined confirmation pathway. Review the authoritative source.

EUCAST disk diffusion and quality control

EUCAST requires standardized methodology, current breakpoint tables, and routine quality control; the laboratory remains responsible for the final susceptibility report. For broth dilution, inoculum density, cation content, pH, incubation atmosphere, endpoint definition, and two-fold dilution design influence MIC reproducibility. Breakpoints are interpretive rules applied after a technically valid MIC or zone measurement; they are not properties of the product alone. Review the authoritative source.

WHO Laboratory Quality Management System handbook

WHO laboratory quality guidance treats document control, equipment, purchasing and inventory, process control, records, occurrence management, and continual improvement as connected parts of reliable testing. Review the authoritative source.

Technical references

  1. Manufacturer product documentation for catalogue 10142.
  2. FDA BAM Chapter 10: Detection of Listeria monocytogenes (access checked 2026-07-20).
  3. EUCAST disk diffusion and quality control (access checked 2026-07-20).
  4. WHO Laboratory Quality Management System handbook (access checked 2026-07-20).

Bench-use checklist

  • Verify product identity, catalogue number, lot, expiry, and storage history.
  • Document preparation and incubation exactly as controlled in the SOP.
  • Define controls and acceptance criteria before testing.
  • Record raw observations, control response, reading time, and confirmation decision.
  • Escalate failed controls, atypical reactions, and departures through the quality system.